These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

496 related items for PubMed ID: 17141452

  • 1. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
    LaPlante KL.
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
    [Abstract] [Full Text] [Related]

  • 2. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report.
    Orrett FA.
    Jpn J Infect Dis; 2008 Mar; 61(2):107-10. PubMed ID: 18362397
    [Abstract] [Full Text] [Related]

  • 3. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
    Dolapçi I, Karahan ZC, Tekeli A, Koyuncu E, Azap A, Adaleti R.
    Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
    [Abstract] [Full Text] [Related]

  • 4. Emergence and spread of low-level mupirocin resistance in methicillin-resistant Staphylococcus aureus isolated from a community hospital in Japan.
    Watanabe H, Masaki H, Asoh N, Watanabe K, Oishi K, Furumoto A, Kobayashi S, Sato A, Nagatake T.
    J Hosp Infect; 2001 Apr; 47(4):294-300. PubMed ID: 11289773
    [Abstract] [Full Text] [Related]

  • 5. Mupirocin resistance in patients colonized with methicillin-resistant Staphylococcus aureus in a surgical intensive care unit.
    Jones JC, Rogers TJ, Brookmeyer P, Dunne WM, Storch GA, Coopersmith CM, Fraser VJ, Warren DK.
    Clin Infect Dis; 2007 Sep 01; 45(5):541-7. PubMed ID: 17682986
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001.
    Kresken M, Hafner D, Schmitz FJ, Wichelhaus TA, Paul-Ehrlich-Society for Chemotherapy.
    Int J Antimicrob Agents; 2004 Jun 01; 23(6):577-81. PubMed ID: 15194128
    [Abstract] [Full Text] [Related]

  • 8. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).
    Desbois AP, Lang S, Gemmell CG, Coote PJ.
    J Appl Microbiol; 2010 Feb 01; 108(2):723-30. PubMed ID: 19709343
    [Abstract] [Full Text] [Related]

  • 9. Antibacterial effect of tea-tree oil on methicillin-resistant Staphylococcus aureus biofilm formation of the tympanostomy tube: an in vitro study.
    Park H, Jang CH, Cho YB, Choi CH.
    In Vivo; 2007 Feb 01; 21(6):1027-30. PubMed ID: 18210750
    [Abstract] [Full Text] [Related]

  • 10. Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit.
    Dajcs JJ, Hume EB, Moreau JM, Caballero AR, Cannon BM, O'Callaghan RJ.
    Invest Ophthalmol Vis Sci; 2000 May 01; 41(6):1432-7. PubMed ID: 10798659
    [Abstract] [Full Text] [Related]

  • 11. In vitro activity of mupirocin and amoxicillin-clavulanate alone and in combination against staphylococci including those resistant to methicillin.
    Alou L, Cafini F, Sevillano D, Unzueta I, Prieto J.
    Int J Antimicrob Agents; 2004 May 01; 23(5):513-6. PubMed ID: 15120734
    [Abstract] [Full Text] [Related]

  • 12. Changes in antibiotic susceptibility in staphylococci habituated to sub-lethal concentrations of tea tree oil (Melaleuca alternifolia).
    McMahon MA, Tunney MM, Moore JE, Blair IS, Gilpin DF, McDowell DA.
    Lett Appl Microbiol; 2008 Oct 01; 47(4):263-8. PubMed ID: 18778374
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC, Foster-Frey J, Donovan DM.
    FEMS Microbiol Lett; 2008 Oct 01; 287(2):185-91. PubMed ID: 18721148
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Synergistic effects of mupirocin and an isoflavanone isolated from Erythrina variegata on growth and recovery of methicillin-resistant Staphylococcus aureus.
    Sato M, Tanaka H, Yamaguchi R, Kato K, Etoh H.
    Int J Antimicrob Agents; 2004 Sep 01; 24(3):241-6. PubMed ID: 15325427
    [Abstract] [Full Text] [Related]

  • 18. Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
    Hammer KA, Carson CF, Riley TV.
    Int J Antimicrob Agents; 2008 Aug 01; 32(2):170-3. PubMed ID: 18571379
    [Abstract] [Full Text] [Related]

  • 19. The in-vitro activity of povidone-iodinecream against Staphylococcus aureus and its bioavailability in nasal secretions.
    Hill RL, Casewell MW.
    J Hosp Infect; 2000 Jul 01; 45(3):198-205. PubMed ID: 10896798
    [Abstract] [Full Text] [Related]

  • 20. Surveillance for mupirocin resistance following introduction of routine peri-operative prophylaxis with nasal mupirocin.
    Fawley WN, Parnell P, Hall J, Wilcox MH.
    J Hosp Infect; 2006 Mar 01; 62(3):327-32. PubMed ID: 16377029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.